BRUNETTO, MAURIZIA ROSSANA Statistiche
BRUNETTO, MAURIZIA ROSSANA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
'e' antigen defective hepatitis B virus and course of chronic infection
1991-01-01 Manzini, P; Calvo, Pl; Chiaberge, E; Abate, Ml; Parrella, T; Barbera, C; Saracco, G; Oliveri, F; Giarin, M; Brunetto, Mr
2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.
2019-01-01 Cornberg, M; Lok, As; Terrault, Na; Zoulim, F; Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hl; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H.
2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.
2019-01-01 Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hly; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H; Afdhal, Nh; Apelian, D; Brown, N; Beumont-Mauviel, M; Cloherty, G; Cornberg, M; Dickens, T; Donaldson, E; Gaggar, A; Given, B; Lopatin, U; Lok, A; Miller, V; Mishra, P; Picchio, G; Revill, P; Schlottmann, S; Terrault, N; Vaillant, A; Vernoux, L; Wang, S; Wat, C; Young, J; Zoulim, F.
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
2018-01-01 Agarwal, Kosh; Brunetto, Maurizia; Seto, Wai Kay; Lim, Young-Suk; Fung, Scott; Marcellin, Patrick; Ahn, Sang Hoon; Izumi, Namiki; Chuang, Wan–long; Bae, Ho; Sharma, Manoj; Janssen, Harry L. A.; Pan, Calvin Q.; Çelen, Mustafa Kemal; Furusyo, Norihiro; Shalimar, Dr; Yoon, Ki Tae; Trinh, Huy; Flaherty, John F.; Gaggar, Anuj; Lau, Audrey H.; Cathcart, Andrea L.; Lin, Lanjia; Bhardwaj, Neeru; Suri, Vithika; Mani Subramanian, G.; Gane, Edward J.; Buti, Maria; Chan, Henry L. Y.
[Evaluation of the usefulness of ultrasonics in the diagnosis of cancerous cirrhosis. Comparison with CT]
1988-01-01 Gandini, G; Brunetto, M; Bonino, F; Regge, D; Fauciglietti, P; Garretti, L
[Is HCV RNA detectable in the ultrafiltrate?]
1996-01-01 Coppo, R; Bonino, F; Verme, G; Martina, G; Brunetto, Mr; Bonaudo, R; Amore, A; Manzini, P
[Use of virus-induced damage markers in the diagnosis of viral hepatitis]
1995-01-01 Brunetto, Mr; Bonino, F; Verme, G; Colombatto, P; Piantino, P; Oliveri, F; Randone, A
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B.
2018-01-01 Lampertico, P; Messinger, D; Cornberg, M; Brunetto, M; Petersen, J; Kennedy, P; Asselah, T; Rothe, V; Caputo, A; Bakalos, G; Pavlovic, V; Papatheodoridis, Gv.
A "systems medicine" approach to the study of non-alcoholic fatty liver disease
2015-01-01 Petta, S; Valenti, L; Bugianesi, E; Targher, G; Bellentani, S; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C.
2015-01-01 Iannazzo, S; Colombatto, P; Ricco, Gabriele; Oliveri, F; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients
2001-01-01 Brunetto, MAURIZIA ROSSANA; Ciccorossi, P; Filipponi, Franco; Giannotti, Alessia; Oliveri, F; Coco, B; Bonino, Ferruccio; Campa, Mario; Mosca, Franco
A multiphase model of th dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alfa2a, lamivudine and combination therapy
2006-01-01 Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A multiphase model of the dynamics of HBV infection in BBeAg-negative patients during pegylated interferon-alpha 2a, lamivudine and combination therapy
2006-01-01 Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, F; Brunetto, Mr
A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2a (40kd) (PEGASYS (R)), lamivudine, or PEGASYS (R) plus lamivudine combin
2004-01-01 Colombatto, P; Bizzarri, R; Civitano, L; Oliveri, F; Bonino, F; Germanidis, G; Farci, P; Kitis, G; Hadziyannis, S; Choudhury, S; Gieschke, R; Zahm, F; Brunetto, M
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B
1990-01-01 Brunetto, MAURIZIA ROSSANA; Stemler, M; Bonino, Ferruccio; Schodel, F; Oliveri, F; Rizzetto, M; Verme, G; Will, H.
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B
1990-01-01 Will, H; Verme, G; Rizzetto, M; Oliveri, F; Schodel, F; Bonino, F; Stemler, M; Brunetto, Mr
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels
1997-01-01 Brunetto, Mr; Bonino, F; Smedile, A; Verme, G; David, E; Volpes, R; Tappero, G; Baldi, M; Oliveri, F; Calleri, G; Medaina, N; Dolci, L; Monti Gorin, G; Civitico, G; Randone, A; Colombatto, P.
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatise serum levels
1997-01-01 Colombatto, P; Randone, A; Civitico, G; MONTI GORIN, G; Dolci, L; Medaina, N; Calleri, G; Oliveri, F; Baldi, M; Tappero, G; Volpes, R; David, E; Verme, G; Smedile, A; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION
2009-01-01 Urbani, Lucio; Colombatto, Piero; Mazzoni, Alessandro; Bindi, Lucia; Biancofiore, GIANDOMENICO LUIGI; Tascini, Carlo; Menichetti, Francesco; Brunetto Maurizia, R.; Scatena, Fabrizio; Filipponi, Franco
A new role for an old marker, HBsAg
2010-01-01 Brunetto, Mr
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'e' antigen defective hepatitis B virus and course of chronic infection | 1-gen-1991 | Manzini, P; Calvo, Pl; Chiaberge, E; Abate, Ml; Parrella, T; Barbera, C; Saracco, G; Oliveri, F; Giarin, M; Brunetto, Mr | |
| 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. | 1-gen-2019 | Cornberg, M; Lok, As; Terrault, Na; Zoulim, F; Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hl; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H. | |
| 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. | 1-gen-2019 | Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hly; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H; Afdhal, Nh; Apelian, D; Brown, N; Beumont-Mauviel, M; Cloherty, G; Cornberg, M; Dickens, T; Donaldson, E; Gaggar, A; Given, B; Lopatin, U; Lok, A; Miller, V; Mishra, P; Picchio, G; Revill, P; Schlottmann, S; Terrault, N; Vaillant, A; Vernoux, L; Wang, S; Wat, C; Young, J; Zoulim, F. | |
| 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection | 1-gen-2018 | Agarwal, Kosh; Brunetto, Maurizia; Seto, Wai Kay; Lim, Young-Suk; Fung, Scott; Marcellin, Patrick; Ahn, Sang Hoon; Izumi, Namiki; Chuang, Wan–long; Bae, Ho; Sharma, Manoj; Janssen, Harry L. A.; Pan, Calvin Q.; Çelen, Mustafa Kemal; Furusyo, Norihiro; Shalimar, Dr; Yoon, Ki Tae; Trinh, Huy; Flaherty, John F.; Gaggar, Anuj; Lau, Audrey H.; Cathcart, Andrea L.; Lin, Lanjia; Bhardwaj, Neeru; Suri, Vithika; Mani Subramanian, G.; Gane, Edward J.; Buti, Maria; Chan, Henry L. Y. | |
| [Evaluation of the usefulness of ultrasonics in the diagnosis of cancerous cirrhosis. Comparison with CT] | 1-gen-1988 | Gandini, G; Brunetto, M; Bonino, F; Regge, D; Fauciglietti, P; Garretti, L | |
| [Is HCV RNA detectable in the ultrafiltrate?] | 1-gen-1996 | Coppo, R; Bonino, F; Verme, G; Martina, G; Brunetto, Mr; Bonaudo, R; Amore, A; Manzini, P | |
| [Use of virus-induced damage markers in the diagnosis of viral hepatitis] | 1-gen-1995 | Brunetto, Mr; Bonino, F; Verme, G; Colombatto, P; Piantino, P; Oliveri, F; Randone, A | |
| A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B. | 1-gen-2018 | Lampertico, P; Messinger, D; Cornberg, M; Brunetto, M; Petersen, J; Kennedy, P; Asselah, T; Rothe, V; Caputo, A; Bakalos, G; Pavlovic, V; Papatheodoridis, Gv. | |
| A "systems medicine" approach to the study of non-alcoholic fatty liver disease | 1-gen-2015 | Petta, S; Valenti, L; Bugianesi, E; Targher, G; Bellentani, S; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA | |
| A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C. | 1-gen-2015 | Iannazzo, S; Colombatto, P; Ricco, Gabriele; Oliveri, F; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA | |
| A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients | 1-gen-2001 | Brunetto, MAURIZIA ROSSANA; Ciccorossi, P; Filipponi, Franco; Giannotti, Alessia; Oliveri, F; Coco, B; Bonino, Ferruccio; Campa, Mario; Mosca, Franco | |
| A multiphase model of th dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alfa2a, lamivudine and combination therapy | 1-gen-2006 | Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA | |
| A multiphase model of the dynamics of HBV infection in BBeAg-negative patients during pegylated interferon-alpha 2a, lamivudine and combination therapy | 1-gen-2006 | Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, F; Brunetto, Mr | |
| A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2a (40kd) (PEGASYS (R)), lamivudine, or PEGASYS (R) plus lamivudine combin | 1-gen-2004 | Colombatto, P; Bizzarri, R; Civitano, L; Oliveri, F; Bonino, F; Germanidis, G; Farci, P; Kitis, G; Hadziyannis, S; Choudhury, S; Gieschke, R; Zahm, F; Brunetto, M | |
| A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B | 1-gen-1990 | Brunetto, MAURIZIA ROSSANA; Stemler, M; Bonino, Ferruccio; Schodel, F; Oliveri, F; Rizzetto, M; Verme, G; Will, H. | |
| A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B | 1-gen-1990 | Will, H; Verme, G; Rizzetto, M; Oliveri, F; Schodel, F; Bonino, F; Stemler, M; Brunetto, Mr | |
| A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels | 1-gen-1997 | Brunetto, Mr; Bonino, F; Smedile, A; Verme, G; David, E; Volpes, R; Tappero, G; Baldi, M; Oliveri, F; Calleri, G; Medaina, N; Dolci, L; Monti Gorin, G; Civitico, G; Randone, A; Colombatto, P. | |
| A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatise serum levels | 1-gen-1997 | Colombatto, P; Randone, A; Civitico, G; MONTI GORIN, G; Dolci, L; Medaina, N; Calleri, G; Oliveri, F; Baldi, M; Tappero, G; Volpes, R; David, E; Verme, G; Smedile, A; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA | |
| A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION | 1-gen-2009 | Urbani, Lucio; Colombatto, Piero; Mazzoni, Alessandro; Bindi, Lucia; Biancofiore, GIANDOMENICO LUIGI; Tascini, Carlo; Menichetti, Francesco; Brunetto Maurizia, R.; Scatena, Fabrizio; Filipponi, Franco | |
| A new role for an old marker, HBsAg | 1-gen-2010 | Brunetto, Mr |